PRoFESS Study Group

Author PubWeight™ 17.26^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Telmisartan to prevent recurrent stroke and cardiovascular events.	N Engl J Med	2008	7.25
2	Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.	N Engl J Med	2008	6.08
3	Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).	Cerebrovasc Dis	2007	1.63
4	Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.	Stroke	2009	0.96
5	Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.	Stroke	2010	0.86
6	Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial.	Int J Stroke	2013	0.82